Maximilian Sandmann received a Poster Award at the FASEB NAD Metabolism Meeting 2026 in Melbourne, Florida, for his presentation on the development of potent inhibitors of SARS-CoV-2 Macrodomain 1 (Mac1). The work, carried out within SFB1328 Project A18, contributes to a deeper understanding of viral macrodomains as antagonists of host immune defenses and supports the development of novel antiviral strategies.
